Natco Pharma to buy over 35% in South Africa's Adcock Ingram

Natco Pharma, based in Hyderabad, is set to acquire a 35.75% stake in Adcock Ingram, South Africa's second-largest drugmaker, for ₹2,000 crore. This all-cash deal provides Natco Pharma with a strong entry into high-growth African markets and expands its product offerings. The acquisition, expected to finalize in four months, aligns with Natco's strategy to grow in emerging markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CVoQfkZ
via IFTTT